Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern

Nat Rev Endocrinol. 2024 May;20(5):314. doi: 10.1038/s41574-024-00976-y.

¹ Endocrine & Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Sunita.DeSousa@sa.gov.au.
² Department of Neurosurgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
³ Endocrine & Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
⁴ Department of Neurosurgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
⁵ Otolaryngology Head & Neck Surgery, University of Adelaide, Adelaide, South Australia, Australia.

No abstract available

Publication types